Stocks of Surgery Partners Inc (NASDAQ:SGRY) traded higher last session on Wall Street, unchanged to $25.75.
SGRY stock price is now 18.81% away from the 50-day moving average and -3.22% away from the 200-day moving average. The market capitalization of the company currently stands at $3.27B.
With the price target of $30, BofA Securities recently initiated with Buy rating for Surgery Partners Inc (NASDAQ: SGRY). On October 14, 2024, UBS recently initiated its ‘Buy’ rating on the stock quoting a target price of $38, while ‘KeyBanc Capital Markets’ rates the stock as ‘Sector Weight’
In other news, Anthony Taparo, Officer bought 6,463 shares of the company’s stock on Jan 16 ’25. The stock was bought for $128,355 at an average price of $19.86. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 05 ’24, Officer Bradley Owens bought 9,241 shares of the business’s stock. A total of $283,652 was incurred on buying the stock at an average price of $30.69. A total of 41.82% of the company’s stock is owned by insiders.
During the past 12 months, Surgery Partners Inc has had a low of $19.50 and a high of $35.29. As of last week, the company has a debt-to-equity ratio of 1.86, a current ratio of 1.80, and a quick ratio of 1.66. The fifty day moving average price for SGRY is $21.6679 and a two-hundred day moving average price translates $26.607124 for the stock.
The latest earnings results from Surgery Partners Inc (NASDAQ: SGRY) was released for 2024-09-30. The net profit margin was -2.03% and return on equity was -3.11% for SGRY. The company reported revenue of $770.4 million for the quarter, compared to $674.1 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 14.29 percent.
